Shorter Courses of Radiotherapy Increasingly Used for Prostate Cancer
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 10, 2023 -- From 2004 to 2020, there was an increase in the use of shorter radiotherapy (RT) courses (hypofractionation) for prostate cancer, according to a brief report published online Oct. 5 in JAMA Oncology.
James B. Yu, M.D., from St. Francis Hospital in Hartford, Connecticut, and colleagues used data from the National Cancer Database to identify the current practice patterns of external beam RT for prostate cancer in the United States. The analysis included 313,062 patients with localized prostate cancer.
The researchers identified a significant temporal pattern of decline in the proportion of patients who received conventional fractionation from 2004 to 2020 (76.0 to 36.6 percent). During the same period, use of moderate hypofractionation and ultrahypofractionation significantly increased (from 22.0 to 45.0 percent and from 2.0 to 18.3 percent, respectively). For patients in the low- and intermediate-risk groups, the most common RT schedule by 2020 was ultrahypofractionation and moderate hypofractionation, respectively. Shorter courses of RT were seen in association with treatment at a community cancer program versus academic or research program, Medicaid versus Medicare insurance, Black versus White race, and higher versus lower median income.
"Reduced adoption was associated with multiple social determinants of health," the authors write. "Realignment of value-based models to appropriately increase reimbursement for hypofractionation may reduce barriers to nationwide adoption and may ensure access to this treatment for underserved communities."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Planetary Health Diet Index Linked to Lower Total, Cause-Specific Mortality
MONDAY, June 10, 2024 -- A higher Planetary Health Diet Index (PHDI) is associated with a lower risk for total and cause-specific mortality, according to a study published online...
Prevalence of Iron Deficiency Varies With Different Definitions
MONDAY, June 10, 2024 -- The prevalence of iron deficiency varies significantly with three different definitions, according to a study published online June 7 in JAMA Network...
AI Blood-Based Lung Cancer Screening Test Developed for Fragmentome
MONDAY, June 10, 2024 -- A novel blood-based lung cancer screening test has been developed and validated using genome-wide sequencing to analyze cell-free DNA (cfDNA)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.